@article{3d7433a4136a443ba668cb9f4b09e8bc,
title = "RTOG 0913: a phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.",
author = "Prakash Chinnaiyan and Minhee Won and Wen, \{Patrick Y.\} and Rojiani, \{Amyn M.\} and Merideth Wendland and Dipetrillo, \{Thomas A.\} and Corn, \{Benjamin W.\} and Mehta, \{Minesh P.\}",
note = "Daily oral everolimus (10 mg) combined with both concurrent radiation and temozolomide followed by adjuvant temozolomide is well tolerated, with an acceptable toxicity profile. A randomized phase 2 clinical trial with mandatory correlative biomarker analysis is currently under way, designed to both determine the efficacy of this regimen and identify molecular determinants of response.",
year = "2013",
month = jan,
day = "8",
doi = "10.1016/j.ijrobp.2013.04.036",
language = "American English",
volume = "86",
journal = "International Journal of Radiation Oncology Biology Physics",
}